{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:26:56Z","timestamp":1790008016214,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Managing hemoptysis can be challenging due to recurrences after different treatment methods. This study aimed to assess the efficacy and long-term outcomes of bronchial artery embolization (BAE) in controlling hemoptysis and improving patient survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective cohort study, patients with hemoptysis undergoing BAE between August 2017 and August 2022 were enrolled and prospectively followed. Clinical characteristics, underlying etiologies, complications, and post-procedural recurrences were prospectively recorded during a 1- to 4-year follow-up period. The survival for each factor was graphed in subgroups by the Kaplan\u2013Meier (KM) curve and presented the estimation of the hazard ratio (HR) with 95% confidence interval (CI) from the univariate Cox proportional hazard (PH) model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 297 patients (32% female, 58% with massive hemoptysis) were included. The mean survival time (MST) for all-cause mortality was 35.9 months (95%\n                      <jats:italic>CI<\/jats:italic>\n                      33.6\u201338.3) and for hemoptysis-related death was 45.1 months (95%\n                      <jats:italic>CI<\/jats:italic>\n                      43.8\u201346.4). The overall recurrence rate was 14.6% at 1-month post-BAE, decreased to 5.7% by the 9th month, and rose again to approximately 20% during long-term follow-up. Recurrence was significantly 71% higher in patients with non-massive hemoptysis (46.6%) compared with those with massive hemoptysis (33.8%,\n                      <jats:italic>OR<\/jats:italic>\n                      \u2009=\u20091.71, 95%\n                      <jats:italic>CI<\/jats:italic>\n                      1.05\u20132.80,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>BAE effectively controls life-threatening hemoptysis with favorable long-term survival and acceptable recurrence rates. Optimized management of the underlying pulmonary disease may further improve BAE outcomes and reduce recurrence risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42155-025-00627-x","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:29:45Z","timestamp":1765607385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of bronchial artery embolization in hemoptysis: longitudinal studyon survival and recurrence"],"prefix":"10.1186","volume":"8","author":[{"given":"Mohammad Sadegh","family":"Keshmiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahamin","family":"Astani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Sadat","family":"Hosseini-Baharanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Sharif-Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Ahmadinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheida","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Ranjbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Saliminejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9960-8854","authenticated-orcid":false,"given":"Shadi","family":"Shafaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"issue":"5","key":"627_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5603\/ARM.2018.0035","volume":"86","author":"DM Springer","year":"2018","unstructured":"Springer DM, Cofta S, Juszkat R, \u017babicki B, Go\u017adzik-Spychalska J, Nowicka A, et al. The effectiveness of bronchial artery embolisation in patients with haemoptysis. Adv Respir Med. 2018;86(5):220\u20136.","journal-title":"Adv Respir Med"},{"issue":"3","key":"627_CR2","doi-asserted-by":"publisher","first-page":"e182","DOI":"10.1097\/CCM.0000000000003578","volume":"47","author":"S Yang","year":"2019","unstructured":"Yang S, Wang J, Kuang T, Gong J, Ma Z, Shen YH, et al. Efficacy and safety of bronchial artery embolization on hemoptysis in chronic thromboembolic pulmonary hypertension: a pilot prospective cohort study. Crit Care Med. 2019;47(3):e182\u20139.","journal-title":"Crit Care Med"},{"issue":"3","key":"627_CR3","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4103\/ejcdt.ejcdt_47_19","volume":"68","author":"G Niazi","year":"2019","unstructured":"Niazi G, Kader MA, Samad SEA, Mahmoud N. Transcatheter bronchial artery embolization in the management of hemoptysis. Egypt J Chest Dis Tuberc. 2019;68(3):416\u201322.","journal-title":"Egypt J Chest Dis Tuberc"},{"issue":"7","key":"627_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.arbr.2016.05.010","volume":"52","author":"R Cordovilla","year":"2016","unstructured":"Cordovilla R, de Bollo Miguel E, Nu\u00f1ez Ares A, Cosano Povedano FJ, Herr\u00e1ez Ortega I, Jim\u00e9nez Merch\u00e1n R. Diagnosis and treatment of hemoptysis. Archivos de Bronconeumolog\u00eda (English Edition). 2016;52(7):368\u201377.","journal-title":"Archivos de Bronconeumolog\u00eda (English Edition)"},{"issue":"1","key":"627_CR5","first-page":"723","volume":"15","author":"MS Keshmiri","year":"2020","unstructured":"Keshmiri MS, Shafaghi S, Sharif-Kashani B, Sadoughi A, Ghorbani F, Naghashzadeh F, et al. Preemptive non-selective bronchial artery angioembolization to reduce recurrence rate of hemoptysis. Multidisciplinary respiratory medicine. 2020;15(1):723.","journal-title":"Multidisciplinary respiratory medicine"},{"issue":"10","key":"627_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/17476348.2018.1507737","volume":"12","author":"A Parrot","year":"2018","unstructured":"Parrot A, Tavolaro S, Voiriot G, Canellas A, Assouad J, Cadranel J, et al. Management of severe hemoptysis. Expert Rev Respir Med. 2018;12(10):817\u201329.","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"627_CR7","first-page":"172","volume":"4","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Zhuang Z, Yang M, Luo J, Zhang W, Yan Z, et al. Bronchial artery embolization for hemoptysis: a systematic review and meta-analysis. J Interv Med. 2021;4(4):172\u201380.","journal-title":"J Interv Med"},{"issue":"1","key":"627_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1148\/122.1.33","volume":"122","author":"J R\u00e9my","year":"1977","unstructured":"R\u00e9my J, Arnaud A, Fardou H, Giraud R, Voisin C. Treatment of hemoptysis by embolization of bronchial arteries. Radiology. 1977;122(1):33\u20137.","journal-title":"Radiology"},{"issue":"1","key":"627_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5334\/jbsr.2310","volume":"105","author":"K Dorji","year":"2021","unstructured":"Dorji K, Hongsakul K, Jutidamrongphan W, Oofuvong M, Geater S. Bronchial artery embolization in life-threatening hemoptysis: outcome and predictive factors. J Belg Soc Radiol. 2021;105(1):5.","journal-title":"J Belg Soc Radiol"},{"key":"627_CR10","volume-title":"Survival analysis a self-learning text","author":"DG Kleinbaum","year":"1996","unstructured":"Kleinbaum DG, Klein M. Survival analysis a self-learning text. Springer; 1996."},{"issue":"10","key":"627_CR11","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jvir.2010.06.014","volume":"21","author":"JF Angle","year":"2010","unstructured":"Angle JF, Siddiqi NH, Wallace MJ, Kundu S, Stokes L, Wojak JC, et al. Quality improvement guidelines for percutaneous transcatheter embolization: Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol. 2010;21(10):1479\u201386.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"627_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5152\/dir.2017.16454","volume":"23","author":"A Panda","year":"2017","unstructured":"Panda A, Bhalla AS, Goyal A. Bronchial artery embolization in hemoptysis: a systematic review. Diagn Interv Radiol. 2017;23(4):307\u201317.","journal-title":"Diagn Interv Radiol"},{"issue":"1","key":"627_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1378\/chest.121.1.95","volume":"121","author":"ML Wong","year":"2002","unstructured":"Wong ML, Szkup P, Hopley MJ. Percutaneous embolotherapy for life-threatening hemoptysis. Chest. 2002;121(1):95\u2013102.","journal-title":"Chest"},{"issue":"Suppl 10","key":"627_CR14","doi-asserted-by":"publisher","first-page":"S1069","DOI":"10.21037\/jtd.2017.06.41","volume":"9","author":"C Radchenko","year":"2017","unstructured":"Radchenko C, Alraiyes AH, Shojaee S. A systematic approach to the management of massive hemoptysis. J Thorac Dis. 2017;9(Suppl 10):S1069\u201386.","journal-title":"J Thorac Dis"},{"issue":"6","key":"627_CR15","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1148\/rg.226015180","volume":"22","author":"W Yoon","year":"2002","unstructured":"Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics. 2002;22(6):1395\u2013409.","journal-title":"Radiographics"},{"issue":"1","key":"627_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12931-021-01820-x","volume":"22","author":"JH Hwang","year":"2021","unstructured":"Hwang JH, Kim JH, Park S, Lee KH, Park SH. Feasibility and outcomes of bronchial artery embolization in patients with non-massive hemoptysis. Respir Res. 2021;22(1):221.","journal-title":"Respir Res"},{"issue":"3","key":"627_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1055\/s-0032-1326936","volume":"29","author":"AC Brown","year":"2012","unstructured":"Brown AC, Ray CE. Anterior spinal cord infarction following bronchial artery embolization. Semin Intervent Radiol. 2012;29(3):241\u20134.","journal-title":"Semin Intervent Radiol"},{"issue":"20","key":"627_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025898","volume":"100","author":"LF Chen","year":"2021","unstructured":"Chen LF, Wang TC, Lin TY, Pao PJ, Chu KC, Yang CH, et al. Does tranexamic acid reduce risk of mortality on patients with hemoptysis? A protocol for systematic review and meta-analysis. Medicine. 2021;100(20):e25898.","journal-title":"Medicine"},{"issue":"2","key":"627_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1183\/09031936.00218214","volume":"46","author":"C Abdulmalak","year":"2015","unstructured":"Abdulmalak C, Cottenet J, Beltramo G, Georges M, Camus P, Bonniaud P, et al. Haemoptysis in adults: a 5-year study using the French nationwide hospital administrative database. Eur Respir J. 2015;46(2):503\u201311.","journal-title":"Eur Respir J"},{"issue":"1","key":"627_CR20","doi-asserted-by":"publisher","first-page":"1616519","DOI":"10.1080\/20018525.2019.1616519","volume":"6","author":"CL Petersen","year":"2019","unstructured":"Petersen CL, Weinreich UM. Five-year follow-up of hemoptysis with no malignancy suspected on chest computed tomography: recurrence, lung cancer and mortality. Eur Clin Respir J. 2019;6(1):1616519.","journal-title":"Eur Clin Respir J"},{"issue":"6","key":"627_CR21","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1159\/000091189","volume":"73","author":"M Tsoumakidou","year":"2006","unstructured":"Tsoumakidou M, Chrysofakis G, Tsiligianni I, Maltezakis G, Siafakas NM, Tzanakis N. A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy. Respiration. 2006;73(6):808\u201314.","journal-title":"Respiration"},{"issue":"3","key":"627_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1752-699X.2009.00158.x","volume":"4","author":"O Uzun","year":"2010","unstructured":"Uzun O, Atasoy Y, Findik S, Atici AG, Erkan L. A prospective evaluation of hemoptysis cases in a tertiary referral hospital. Clin Respir J. 2010;4(3):131\u20138.","journal-title":"Clin Respir J"},{"issue":"6","key":"627_CR23","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.55730\/1300-0144.5534","volume":"52","author":"ST \u00d6n\u00fcr","year":"2022","unstructured":"\u00d6n\u00fcr ST, Altin S, Akyil FT, Kara K, S\u00f6k\u00fcc\u00fc SN, \u00d6zdemir C, et al. Management of recurrent hemoptysis: a single-center experience. Turk J Med Sci. 2022;52(6):1872\u201380.","journal-title":"Turk J Med Sci"},{"issue":"1","key":"627_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-023-02371-1","volume":"23","author":"H Li","year":"2023","unstructured":"Li H, Ding X, Zhai S, Gao K. A retrospective study on the management of massive hemoptysis by bronchial artery embolization: risk factors associated with recurrence of hemoptysis. BMC Pulm Med. 2023;23(1):1\u20139.","journal-title":"BMC Pulm Med"},{"key":"627_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00270-009-9788-z","volume":"33","author":"J-Y Chun","year":"2010","unstructured":"Chun J-Y, Morgan R, Belli A-M. Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Intervent Radiol. 2010;33:240\u201350.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"627_CR26","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.2214\/AJR.20.22775","volume":"215","author":"S Xu","year":"2020","unstructured":"Xu S, Guan L-J, Shi B-Q, Tan Y-S, Zhang X-J. Recurrent hemoptysis after bronchial artery embolization: prediction using a nomogram and artificial neural network model. AJR Am J Roentgenol. 2020;215(6):1490\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"627_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/BF02735578","volume":"15","author":"K Hayakawa","year":"1992","unstructured":"Hayakawa K, Tanaka F, Torizuka T, Mitsumori M, Okuno Y, Matsui A, et al. Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc Intervent Radiol. 1992;15:154\u20138.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"627_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000264921","volume":"80","author":"A Delage","year":"2010","unstructured":"Delage A, Tillie-Leblond I, Cavestri B, Wallaert B, Marquette CH. Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome. Respiration. 2010;80(5):387\u201392.","journal-title":"Respiration"},{"issue":"3","key":"627_CR29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.rmed.2011.11.010","volume":"106","author":"YJ Lee","year":"2012","unstructured":"Lee YJ, Lee SM, Park JS, Yim JJ, Yang SC, Kim YW, et al. The clinical implications of bronchoscopy in hemoptysis patients with no explainable lesions in computed tomography. Respir Med. 2012;106(3):413\u20139.","journal-title":"Respir Med"},{"issue":"2","key":"627_CR30","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1378\/chest.112.2.440","volume":"112","author":"B Hirshberg","year":"1997","unstructured":"Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest. 1997;112(2):440\u20134.","journal-title":"Chest"},{"issue":"3","key":"627_CR31","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0022-5223(19)34221-7","volume":"105","author":"CJ Knott-Craig","year":"1993","unstructured":"Knott-Craig CJ, Oostuizen JG, Rossouw G, Joubert JR, Barnard PM. Management and prognosis of massive hemoptysis recent experience with 120 patients. J Thorac Cardiovasc Surg. 1993;105(3):394\u20137.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"627_CR32","first-page":"232","volume":"6","author":"T-W Lee","year":"2000","unstructured":"Lee T-W, Wan S, Choy D, Chan M, Arifi A, Yim A. Management of massive hemoptysis: a single institution experience. Ann Thorac Cardiovasc Surg. 2000;6(4):232\u20135.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"627_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00134-002-1553-6","volume":"29","author":"T-H Ong","year":"2003","unstructured":"Ong T-H, Eng P. Massive hemoptysis requiring intensive care. Intensive Care Med. 2003;29:317\u201320.","journal-title":"Intensive Care Med"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-025-00627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-025-00627-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-025-00627-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T19:02:39Z","timestamp":1765652559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42155-025-00627-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["627"],"URL":"https:\/\/doi.org\/10.1186\/s42155-025-00627-x","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"20 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Iran National Committee for Ethics in Biomedical Research (Ethic code: IR.SBMU.NRITLD.REC.1402.006) and was conducted in full compliance with the ethical principles outlined in the Declaration of Helsinki. Informed consent was obtained from all participants before their inclusion in the study, ensuring they were fully aware of the study\u2019s objectives, procedures, potential risks, and benefits.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}